首页> 外文期刊>BJU international >Extracorporeal shockwave lithotripsy vs ureteroscopy as first-line therapy for patients with single, distal ureteric stones: a prospective randomized study.
【24h】

Extracorporeal shockwave lithotripsy vs ureteroscopy as first-line therapy for patients with single, distal ureteric stones: a prospective randomized study.

机译:体外冲击波碎石术与输尿管镜作为单根,远端输尿管结石患者的一线治疗:一项前瞻性随机研究。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To compare extracorporeal shockwave lithotripsy (ESWL) and ureteroscopy (URS) as first-line treatments for patients with distal ureteric stones. PATIENTS AND METHODS: In all, 273 patients with single, monolateral, radiopaque, distal ureteric stones of 0.5-1.5 cm were enrolled in a prospective randomized trial. Patients were randomized to undergo ESWL (137) or URS (136). The electromagnetic Modulith SLX lithotripter (Storz Medical, Switzerland) was used for ESWL and a semi-rigid ureteroscope was used for URS. Patients in both groups were compared for overall stone-free rates (SFRs), re-treatment rates, need for auxiliary procedures and complication rates. A subgroup analysis was performed in both groups according to stone size of 1 cm. RESULTS: Patients in the ESWL group achieved a 92.70% overall SFR with a 44.88% re-treatment rate and an 11.02% auxiliary procedure rate. Complications occurred in 15.32% of patients treated with ESWL. Patients in the URS group achieved a 94.85% overall SFR with a re-treatment rate of 7.75% and an auxiliary procedure rate of 18.60%. Complications occurred in 19.11% of patients treated with URS. In the ESWL group, the need for re-treatments and for auxiliary procedures as well as the incidence of complications was significantly higher in patients with stones of >1 cm. In patients with stones of 1 cm.
机译:目的:比较体外冲击波碎石术(ESWL)和输尿管镜检查(URS)作为输尿管远端结石患者的一线治疗方法。患者与方法:共有273例单侧,单侧,不透射线,远端输尿管结石0.5-1.5 cm的患者参加了一项前瞻性随机试验。患者被随机分为ESWL(137)或URS(136)。 ESWL使用电磁Modulith SLX碎石机(瑞士Storz Medical),URS使用半刚性输尿管镜。比较两组患者的总无结石率(SFR),再治疗率,辅助手术需要和并发症发生率。两组均根据 1 cm的结石大小进行了亚组分析。结果:ESWL组患者的总SFR达到92.70%,再治疗率为44.88%,辅助手术率为11.02%。 ESWL治疗的患者中发生并发症的比例为15.32%。 URS组的患者总体SFR为94.85%,再治疗率为7.75%,辅助手术率为18.60%。接受URS治疗的患者中发生并发症的比例为19.11%。在ESWL组中,结石> 1 cm的患者对再治疗和辅助程序的需求以及并发症的发生率明显更高。在用ESWL治疗的 1 cm的患者应保留URS。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号